-opt.jpg)
Where biotech, AI and quantum converge
Sahlgrenska Science Park is leading the development of a national BioConvergence initiative at the intersection of biotechnology, artificial intelligence and quantum technologies. The initiative has received approximately SEK 1.1 million in planning support from Vinnova to establish a strong foundation for realizing the vision of a globally leading BioConvergence Excellence Cluster, positioning Sweden at the forefront of next-generation life science and health innovation.
The initiative brings together actors across health, data and technology to shape a shared vision, initiate international partnerships and define a long-term collaboration and implementation roadmap.
Why BioConvergence
BioConvergence creates new opportunities to address complex healthcare and societal challenges by integrating biological innovation with advanced digital technologies.
It enables progress in areas such as:
precision health and diagnostics
data-driven research and innovation
scalable and sustainable life science solutions
By connecting disciplines and sectors, BioConvergence accelerates the translation of research into real-world impact.
A strong cross-sector collaboration
The initiative is coordinated by Sahlgrenska Science Park in collaboration with more than 20 partners from across Sweden’s life science and technology ecosystems. Together, the partners contribute complementary expertise at the intersection of biotech, AI and quantum technologies. The work is designed to ensure both strategic alignment and practical feasibility for long-term cluster development and aims to strengthen Sweden’s global competitiveness and international leadership in BioConvergence-driven life science innovation.
